HLS Therapeutics Inc. - Company Profile

BioCentury | Jun 30, 2018

Finance

Eyes on launches

...TTR)-mediated amyloidosis Submit NDA in Japan; PDUFA date Mid-2018; 8/11/18 Amarin Corp. plc (NASDAQ:AMRN) / HLS Therapeutics Inc....

BioCentury | Jan 6, 2018

Finance

...porphyrias Interim Ph III ENVISION data; submit NDA Mid-2018; YE18 Amarin Corp. plc (NASDAQ:AMRN) / HLS Therapeutics Inc....

Items per page:

1 - 2 of 2

BioCentury | Jun 30, 2018

Finance

...TTR)-mediated amyloidosis Submit NDA in Japan; PDUFA date Mid-2018; 8/11/18 Amarin Corp. plc (NASDAQ:AMRN) / HLS Therapeutics Inc....

BioCentury | Jan 6, 2018

Finance

...porphyrias Interim Ph III ENVISION data; submit NDA Mid-2018; YE18 Amarin Corp. plc (NASDAQ:AMRN) / HLS Therapeutics Inc....

Items per page:

1 - 2 of 2